Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza a H7N9 virus infection from Jiangsu province, Eastern China

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Ji, Hong ^a   Gu, Qin ^b   Chen, Li Ling ^c   Xu, Ke ^a   Ling, Xia ^d   Bao, Chang Jun ^a   Tang, Fen Yang ^a   Qi, Xian ^a   Wu, Ying Qiu ^e   Ai, Jing ^a   Shen, Gu Yu ^f   Dong, Dan Jiang ^b   Yu, Hui Yan ^a   Huang, Mao ^f   Cao, Quan ^f   Xu, Ying ^e   Zhao, Wei ^g   Xu, Yang Ting ^h   Xia, Yu ^c   Chen, Shan Hui ^d   Yang, Gen Lin ^f   Gu, Cai Ling ^e   Xie, Guo Xiang ^h   Zhu, Yefei ^a   Zhu, Feng Cai ^a   Zhou, Ming Hao ^a   more..

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c Suzhou Municipal Center for Disease Control and Prevention   (China)

^d Wuxi Center for Disease Control and Prevention   (China)

^e SOOCHOW UNIVERSITY   (China)

^f NANJING MEDICAL UNIVERSITY   (China)

^g Nanjing Second Hospital   (China)

^h NANJING MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHINA; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INFLUENZA A; INFLUENZA A (H7N9); LYMPHOCYTOPENIA; MALE; MORTALITY; OXYGEN CONSUMPTION; PNEUMONIA; RISK FACTOR; ANIMAL; AVIAN INFLUENZA; BIRD; INFLUENZA VIRUS A H7N9; INFLUENZA, HUMAN; MIDDLE AGED; PHYSIOLOGY; SURVIVAL; TREATMENT OUTCOME; VIROLOGY;

AGED; ANIMALS; BIRDS; CHINA; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84897010697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089581     Document Type: Article

References (33)

1. Wong SS, Yuen KY (2006) Avian influenza virus infections in humans. Chest 129: 156-168. (Pubitemid 43265257)
2. WHO. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO,2003-2013.
3. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, et al. (2004) Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363: 587-593. (Pubitemid 38264175)
4. Gao HN, Lu HZ, Cao B, Du B, Shang H, et al. (2013) Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 368: 2277-2285.
5. Yu H, Cowling BJ, Feng L, Lau EH, Liao Q, et al. (2013) Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 382: 138-145.
6. Li Q, Zhou L, Zhou M, Chen Z, Li F, et al. (2013) Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. N Engl J Med.
7. Lu S, Zheng Y, Li T, Hu Y, Liu X, et al. (2013) Clinical Findings for Early Human Cases of Influenza A(H7N9) Virus Infection, Shanghai, China. Emerg Infect Dis 19.
8. Mei Z, Lu S, Wu X, Shao L, Hui Y, et al. (2013) Avian Influenza A(H7N9) Virus Infections, Shanghai, China. Emerg Infect Dis 19.
9. WHO Human infection with avian influenza A(H7N9) virus - update.
10. Liu S, Sun J, Cai J, Miao Z, Lu M, et al. (2013) Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China. J Infect.
11. Commission CNHaFP Diagnostic and treatment protocol for human infections with avian influenza A (H7N9). 2nd ed.
12. Gao R, Cao B, Hu Y, Feng Z, Wang D, et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368: 1888-1897.
13. Cowling BJ, Freeman G, Wong JY, Wu P, Liao Q, et al. (2013) Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013. Euro Surveill 18: 20475.
14. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, et al. (2009) Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 48: 1639-1646.
15. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358: 261-273.
16. Smallman-Raynor M, Cliff AD (2007) Avian influenza A (H5N1) age distribution in humans. Emerg Infect Dis 13: 510-512. (Pubitemid 46348146)
17. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, et al. (2008) Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 205: 711-723. (Pubitemid 351439315)
18. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, et al. (2007) Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4: e59.
19. Nicoll A, Ciancio B, Tsolova S, Blank P, Yilmaz C (2008) The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Euro Surveill 13.
20. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, et al. (2004) Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 125: 2011-2020. (Pubitemid 38788164)
21. Guan Y, Farooqui A, Zhu H, Dong W, Wang J, et al. (2013) H7N9 Incident, immune status, the elderly and a warning of an influenza pandemic. J Infect Dev Ctries 7: 302-307.
22. Bermejo-Martin JF, Almansa R, Ortiz de Lejarazu R (2013) Weakened immunity in aged hosts with comorbidities as a risk factor for the emergence of influenza A H7N9 mutants. J Infect Dev Ctries 7: 497-498.
23. Louie JK, Acosta M, Winter K, Jean C, Gavali S, et al. (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302: 1896-1902.
24. Hien ND, Ha NH, Van NT, Ha NT, Lien TT, et al. (2009) Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Emerg Infect Dis 15: 19-23.
25. Yu H, Gao Z, Feng Z, Shu Y, Xiang N, et al. (2008) Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 3: e2985.
26. Lee EH, Wu C, Lee EU, Stoute A, Hanson H, et al. (2010) Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 50: 1498-1504.
27. Shinde V, Hanshaoworakul W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, et al. (2011) A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006. PLoS One 6: e14809.
28. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, et al. (2005) Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352: 686-691. (Pubitemid 40239216)
29. Cao B, Li XW, Mao Y, Wang J, Lu HZ, et al. (2009) Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 361: 2507-2517.
30. Yu H, Feng Z, Uyeki TM, Liao Q, Zhou L, et al. (2011) Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 52: 457-465.
31. Adisasmito W, Chan PK, Lee N, Oner AF, Gasimov V, et al. (2010) Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis 202: 1154-1160.
32. Kuehn BM (2013) CDC: Use antivirals early, aggressively for H7N9 flu. JAMA 309: 2086.
33. WHO. Frequently Asked Questions on human infection caused by the avian influenza A(H7N9) virus.